PURETECH HEALTH PLC - ADR
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About PRTC
PureTech Health plc is a clinical-stage company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company is engaged in the development of around 29 therapeutics and therapeutic candidates, including three that have been approved by the United States Food and Drug Administration. A number of these programs are advanced by the Company or its Founded Entities in various indications and stages of clinical development. Its primary programs include LYT-100 and LYT-200. Deupirfenidone (LYT-100) is being developed as a potential new standard of care (SOC) for the treatment of idiopathic pulmonary fibrosis (IPF). LYT-200 is an anti-galectin-9 monoclonal antibody (mAb) being developed for the treatment of hematological malignancies, including acute myeloid leukemia (AML) and high-risk myelodysplastic syndromes (MDS), as well as solid tumors, including head and neck cancers, with a focus on metastatic disease.
Find out what a historical investment in PURETECH HEALTH PLC - ADR would be worth today using our PRTC stock calculator.
$417.36M
-
0.00%
286
$17.44
$17.44
$17.44
$26.79
$13.30
Ready to start your investing journey with Stake?
Open an accountPRTC FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in PRTC
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in PRTC
on Stake
Buy PRTC from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of PRTC from only US$10 with fractional shares
